🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

According to the social media company, the platform has removed problematic material and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for mixing or injecting at home.

Within moments of entering one group, a seller posted contact information, where most transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these groups, posts show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious medical dangers”.